BOSTON - (May 1, 2020) - Excess white fat causes obesity, which in turn can drive diabetes and many other metabolic diseases that are growing at epidemic rates around the world. But all white fat is not born equal. For instance, "intra-abdominal" fat, i.e. fat within the belly, is known to carry higher risks of disease than "subcutaneous" fat that sits under the skin and often accumulates in the hips and thighs. Researchers from Joslin Diabetes Center and Boston University now have discovered different types of white fat cells, even within a single site, that may play distinct roles in disease.
"A central question in our research on metabolic disease is whether white fat cells in different parts of the body, and even within a single part of the body, are different enough that some might predispose you to disease and some might not," says C. Ronald Kahn, MD, Joslin's Chief Academic Officer and Head of the Section on Integrative Physiology and Metabolism. "If so, determining the mechanisms for these differences could lead to development of novel therapies for diabetes, obesity and related conditions."
Earlier studies had identified several types of white fat cells in mice, but this is one of the first to discover multiple types in humans, says Kahn, who is co-senior author on a Nature Communications paper presenting the work and professor at Harvard Medical School.
Within fat tissue, fat cells evolve from "preadipocytes" or precursor cells to mature cells. As they do, their patterns of gene expression change. A technique called single-cell RNA sequencing examines these expression patterns on a cell-by-cell basis, offering an extremely detailed look at how the patterns vary between cells.
The collaboration between Joslin and Boston University began with two sets of single-cell RNA sequencing data on human subcutaneous white fat preadipocytes that progressed into mature stages in culture. Gathered from healthy humans, one data set was collected by scientists at the Broad Institute of Harvard and MIT and the other by the lab of Joslin's Yu-Hua Tseng, PhD.
Simon Kasif, PhD, Boston University professor of biomedical engineering and co-senior author on the paper, then led an integrated analysis of both data sets with a novel mathematical approach to understanding the patterns of gene expression in these cells.
The analysis identified two subtypes of human white subcutaneous fat that displayed quite distinct patterns of gene expression. Among the distinctions, one subtype showed patterns indicating much higher intake of glucose, a crucial resource in metabolism.
Additionally, the investigators found that "zinc nuclear finger" genes, a group of master regulator genes whose function in fat cells is not well understood, were expressed at much higher levels in one class of preadipocytes. This expression may help to control whether the cells become mature fat cells, the scientists suggested.
"We think this research is the tip of the iceberg--if we study more samples of human fat, we will find more subtypes," says Kahn. It would be very helpful, for instance, to examine samples of intra-abdominal fat and fat from people with various metabolic conditions. Broadening the research into white fat cell types would aid in connecting various patterns of obesity with the risks and mechanisms of metabolic disease, he says.
"Body fat is linked to many different conditions beyond diabetes," Kahn emphasizes. "This research could be important for understanding the risk factors for other metabolic diseases such as fatty liver disease and atherosclerosis, and even non-metabolic diseases that are increased by obesity, such as cancer and Alzheimer's disease."
"The study highlights the potential of bringing interdisciplinary expertise from four laboratories to integrate biology, artificial intelligence, systems biology and data obtained from clinical samples to catalyze discovery," says Kasif.
"Metabolic diseases are highly associated with environmental factors," Kasif adds. "This work supports the relatively understudied hypothesis that environmental factors may modify the trajectory of how cells develop and our understanding of how this process may influence biology and metabolic disease."
Alfred Ramirez, then a graduate student at Boston University, was first author on the paper. Other contributors included Weikang Cai, Ruidan Xue and Yu-Hua Tseng from Joslin; Bashir Rastegarpanah and Mark Crovella from Boston University; and Simon Dankel from the University of Bergen in Norway. Lead funding for the work came from the National Institutes of Health and the National Science Foundation.
About Joslin Diabetes Center
Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 16 NIH-designated Diabetes Research Centers in the U.S.
For more information, visit http://www.joslin.org or follow @joslindiabetes | One Joslin Place, Boston, MA 617-309-2400